Company: STAA
Filing Date: 2025-09-18
Form Type: DFAN14A
Source: 0001213900-25-088801
Chunk: 1

Company: STAAR SURGICAL CO
Filing Date: 2025-09-18
Form: DFAN14A
Chunk 1
---
 Participants have filed a preliminary proxy statement and intend to file with the SEC a definitive proxy statement
and accompanying GREEN Proxy Card to be used in connection with any such solicitation of proxies from the Company’s
stockholders for the Special Meeting. STOCKHOLDERS OF THE COMPANY ARE URGED TO READ THESE MATERIALS (INCLUDING ANY AMENDMENTS OR SUPPLEMENTS THERETO) AND ANY OTHER RELEVANT DOCUMENTS THAT THE PARTICIPANTS WILL FILE WITH THE SEC WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION, INCLUDING ABOUT THE MATTERS TO BE VOTED ON AT THE SPECIAL MEETING AND additional information relating to the Participants and their direct or indirect interests, by security holdings or otherwise. The definitive
proxy statement and an accompanying GREEN Proxy Card will be furnished to some or all of the Company’s stockholders
and will be, along with other relevant documents, available at no charge on the SEC’s website at https://www.sec.gov.

Information about the Participants and a description
of their direct or indirect interests, by security holdings or otherwise, is contained on an amendment to Schedule 13D filed by the Participants
with the SEC on September 17, 2025 and is available here.

Exhibit 1

| SECURITIES AND EXCHANGE COMMISSION                                                              
 Washington, D.C. 20549                                                                          |
| SCHEDULE 13D                                                                                    
 Under the Securities Exchange Act of 1934                                                       
 (Amendment No. 37)*                                                                             |
| STAAR SURGICAL CO                                                                               |
| (Name of Issuer)                                                                                |
| Common Stock, par value $0.01 per share                                                         |
| (Title of Class of Securities)                                                                  |
| 852312305                                                                                       |
| (CUSIP Number)                                                                                  |
| Neal C. Bradsher                                                                                
 c/o Broadwood Capital, Inc.                                                                     
 156 West 56th Street, 3rd Floor                                                                 
 New York, NY, 10019                                                                             
 (212) 508-5735                                                                                  |
| (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) |
| 09/15/2025                                                                                      |
| (Date of Event Which Requires Filing of This Statement)                                         |

| If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-